Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDQuarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 1 | -$0.08 | -$0.07 | -$0.08 |
Q2 2024 | 1 | -$0.07 | -$0.07 | -$0.07 |
Q3 2024 | 1 | -$0.08 | -$0.07 | -$0.08 |
Q4 2024 | 1 | -$0.08 | -$0.07 | -$0.08 |
Q1 2025 | 1 | -$0.08 | -$0.07 | -$0.08 |
Q2 2025 | 1 | -$0.07 | -$0.06 | -$0.07 |
Q3 2025 | 1 | -$0.07 | -$0.06 | -$0.07 |
Q4 2025 | 1 | -$0.06 | -$0.06 | -$0.06 |
IceCure Medical Ltd last posted its earnings results on Tuesday, August 20th, 2024. The company reported $-0.06 earnings per share for the quarter, topping analysts' consensus estimates of $-0.07 by $0.01. The company had revenue of 662,000 for the quarter and had revenue of 3.23 M for the year. IceCure Medical Ltd has generated $0 earnings per share over the last year ($-0.32 diluted earnings per share) and currently has a price-to-earnings ratio of -3.77. IceCure Medical Ltd has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, February 3rd, 2025 based on prior year's report dates.
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
11/26/2024 | Q3 2024 | $0.00 | $708,500 | $662,000 | ||
08/20/2024 | Q2 2024 | -$0.07 | -$0.06 | 0.01 | $925,500 | $1.01 M |
05/28/2024 | Q1 2024 | -$0.08 | -$0.08 | 0 | $736,350 | |
04/03/2024 | Q4 2023 | -$0.07 | -$0.07 | 0 | $1.32 M | |
09/29/2023 | Q3 2023 | -$0.09 | $1.02 M | $327,000 | ||
08/14/2023 | Q2 2023 | -$0.09 | -$0.09 | 0 | $934,333 | $937,000 |
03/29/2023 | Q1 2023 | -$0.09 | -$0.08 | 0.01 | $710,000 | |
03/29/2023 | Q4 2022 | -$0.09 | -$0.11 | -0.02 | $939,000 | |
12/05/2022 | Q3 2022 | -$0.11 | -$0.11 | 0 | $634,000 | |
09/22/2022 | Q2 2022 | -$0.13 | $765,000 | |||
09/22/2022 | Q1 2022 | -$0.12 | $747,000 | |||
04/01/2022 | Q4 2021 | -$0.10 | $1.38 M | |||
09/23/2021 | Q3 2021 | -$0.09 | $681,000 | |||
09/23/2021 | Q2 2021 | -$0.09 | $637,000 | |||
03/31/2021 | Q1 2021 | -$0.07 | $1.44 M | |||
12/30/2020 | Q4 2020 | -$0.03 | $1.38 M | |||
09/29/2020 | Q3 2020 | -$0.09 | $635,000 | |||
06/29/2020 | Q2 2020 | -$0.05 | $927,500 | |||
03/30/2020 | Q1 2020 | -$0.05 | $927,500 | |||
12/30/2019 | Q4 2019 | -$0.08 | $539,194 |
IceCure Medical Ltd has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, February 3rd, 2025 based off last year's report dates.
In the previous quarter, IceCure Medical Ltd (:ICCM) reported $-0.06 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.07 by $0.01.
The conference call for IceCure Medical Ltd's latest earnings report can be listened to online.
The conference call transcript for IceCure Medical Ltd's latest earnings report can be read online.
IceCure Medical Ltd (:ICCM) has a recorded annual revenue of $3.23 M.
IceCure Medical Ltd (:ICCM) has a recorded net income of $3.23 M. IceCure Medical Ltd has generated $-0.32 earnings per share over the last four quarters.
IceCure Medical Ltd (:ICCM) has a price-to-earnings ratio of -3.77 and price/earnings-to-growth ratio is -0.13.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED